eNauka - pregled
Pregled prema Autor Moy Beverly
Prikaz rezultata 1 do 2 od 2
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2023 | Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial | Holmes Frankie A; Moy Beverly; Delaloge Suzette; Chia Stephen KL; Ejlertsen Bent; Mansi Janine; Iwata Hiroji; Gnant Michael; Buyse Marc; Barrios Carlos H;
Silovski Tajana; Šeparović Robert; Bashford Anna; Zotano Guerrero Angel; Dendeluri Neelima; Patt Debra; Gokmen Erhan; Gore Ira; Smith II John W; Loibl Sibylle; Masuda Norikazu; Tomašević Zorica
  ; Petrakova Katarina; DiPrimeo Daniel; Wong Alvin; Martin Miguel; Chan Arlene; ExteNET Study Group; | Naučni članak | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
| 2019 | PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial | Chia Stephen K. L.; Miguel Martin; Holmes Frankie A.; Ejlertsen Bent; Delaloge Suzette; Moy Beverly; Iwata Hiroji; von Minckwitz Gunter; Mansi Janine; Barrios Carlos H;
Gnant Michael; Tomašević Zorica; Denduluri Neelima; Šeparović Robert; Kim Sung-Bae; Jakobsen Erik Hugger; Harvey Vernon; Robert Nicholas; Smith II John; Harker Graydon; Zhang Bo; Eli Lisa D; Ye Yining; Lalani Alshad S; Buyse Marc; Chan Arlene;
| Naučni članak | 21aM21a - Vodeći međunarodni časopis kategorije M21a |